|
Re: Renal and Fabry trial listings updated on ClinicalTrials.gov
|
4
|
Resverlogix Corp.
|
Apr 20, 2018 10:49PM
|
|
Re: Renal and Fabry trial listings updated on ClinicalTrials.gov
|
5
|
Resverlogix Corp.
|
Apr 21, 2018 12:05PM
|
|
Re: Reminds me of.......
|
5
|
Resverlogix Corp.
|
Jun 25, 2019 10:57AM
|
|
Re: Reminds me of.......
|
3
|
Resverlogix Corp.
|
Jun 25, 2019 02:24PM
|
|
Re: Reminder: Resverlogix to Hold Conference Call and Webcast on December 6th, 2019
|
4
|
Resverlogix Corp.
|
Dec 05, 2019 08:57PM
|
|
Re: Relax Non Zenith Holders
|
2
|
Resverlogix Corp.
|
Nov 16, 2016 04:52PM
|
|
Re: Regarding that UCSF study identifying 69 targets - someone made this comment
|
1
|
Resverlogix Corp.
|
Apr 04, 2020 12:11AM
|
|
Re: REDUCE-IT CVOT Meets Primary Endpoint
|
5
|
Resverlogix Corp.
|
Sep 24, 2018 12:09PM
|
|
Re: REDUCE-IT CVOT Meets Primary Endpoint
|
5
|
Resverlogix Corp.
|
Sep 24, 2018 12:22PM
|
|
Re: ReCvr
|
3
|
Resverlogix Corp.
|
Sep 25, 2017 01:59PM
|
|
Re: Reconciliation of comments made
|
5
|
Resverlogix Corp.
|
Oct 31, 2016 05:09PM
|
|
Re: Recent findings point to BET protein and ACE2 inhibition as possible means to slow and reduce the impact of COVID-19....
|
9
|
Resverlogix Corp.
|
Mar 23, 2020 08:47PM
|
|
Re: Recent ESC 2017 meeting and Steve Nissans comments
|
4
|
Resverlogix Corp.
|
Sep 11, 2017 10:19AM
|
|
Re: Recent ESC 2017 meeting and Steve Nissans comments
|
4
|
Resverlogix Corp.
|
Sep 11, 2017 10:27AM
|
|
Re: Recent ESC 2017 meeting and Steve Nissans comments
|
5
|
Resverlogix Corp.
|
Sep 11, 2017 11:21AM
|
|
Re: Recent ESC 2017 meeting and Steve Nissans comments
|
2
|
Resverlogix Corp.
|
Sep 11, 2017 02:31PM
|
|
Re: Recent ESC 2017 meeting and Steve Nissans comments
|
3
|
Resverlogix Corp.
|
Sep 09, 2017 06:33PM
|
|
Re: Recent changes
|
1
|
BIOASIS TECHNOLOGIES INC
|
Mar 31, 2019 06:12PM
|
|
Re: Recent changes
|
1
|
BIOASIS TECHNOLOGIES INC
|
Mar 31, 2019 06:17PM
|
|
Re: Rebuys start at $2.28
|
5
|
Resverlogix Corp.
|
Aug 09, 2018 05:38PM
|
